Placebo News and Research

RSS

$SGLT2 inhibitors reduce cardiovascular events among heart failure patients with mildly reduced and preserved ejection fraction$

SGLT2 inhibitors reduce cardiovascular events among heart failure patients with mildly reduced and preserved ejection fraction

An analysis of more than 12,000 patients has found that the SGLT2 inhibitors dapagliflozin and empagliflozin reduce cardiovascular death or hospitalization for heart failure by 20% in heart failure patients with mildly reduced and preserved ejection fraction.

28 Aug 2022

Adding acetazolamide to intravenous loop diuretics decreases congestion in patients with acute decompensated heart failure

Acetazolamide added to intravenous loop diuretics decreases congestion within three days in patients with acute decompensated heart failure, according to late breaking research presented in a Hot Line session today at ESC Congress 2022.

28 Aug 2022

Sociology professor finds three distinct themes in anti-COVID-19 vaccination protest slogans

When the Biden administration announced COVID-19 vaccine mandates on Nov. 4 for businesses with 100 or more employees, protests erupted in cities across the U.S.

26 Aug 2022

New study investigates a potential treatment for people diagnosed with monkeypox

The team behind the world-leading RECOVERY trial of COVID-19 treatments are leading a new study investigating a potential treatment for people who have been diagnosed with monkeypox.

25 Aug 2022

The safety, tolerability, and pharmacokinetics of a muco-trapping monoclonal antibody delivered by inhalation

Researchers conducted a phase I clinical trial of IN-006, an inhaled monoclonal antibody treatment for COVID-19.

24 Aug 2022

Glucokinase activator AZD1656 shows potential benefit for diabetics with moderate to severe COVID-19

A new study examines the potential benefit of the glucokinase activator molecule AZD1656 in the ARCADIA trial.

23 Aug 2022

Direct acting antiviral medications for hepatitis C may improve PTSD symptoms

More than six percent of Americans will develop posttraumatic stress disorder (PTSD) in their lifetime. This potentially chronic condition disrupts lives, and can lead to or exacerbate existing health issues such as depression, anxiety, eating disorders, and suicidal thoughts.

22 Aug 2022

The effectiveness of three repurposed drugs in preventing serious SARS-CoV-2 infection in non-hospitalized adults

Researchers conducted a phase III clinical trial to test the effectiveness of three repurposed drugs - metformin, ivermectin, and fluvoxamine, in preventing progression to severe COVID-19.

22 Aug 2022

The BCG vaccine against COVID-19 and other infectious diseases in type 1 diabetic adults

A recent article demonstrated that BCG vaccinations might offer a platform for protection against emerging SARS-CoV-2 variants and other pathogenic infections in type 1 diabetics.

17 Aug 2022

Vitamin D promising for depression, study says

An extensive meta-analysis suggests that vitamin D supplementation may alleviate depressive symptoms in adults with depression. Conducted by an international team of researchers, the meta-analysis includes dozens of studies from around the world.

12 Aug 2022

Azelastine nasal spray could decrease SARS-CoV-2 load

A new study illustrated that early azelastine nasal spray therapy might lower the SARS-CoV-2 load among virus-infected patients.

11 Aug 2022

Monoclonal antibody decreases asthma attacks by 27% in children and adolescents of color

A monoclonal antibody, mepolizumab, decreased asthma attacks by 27% in Black and Hispanic children and adolescents who have a form of severe asthma, are prone to asthma attacks and live in low-income urban neighborhoods, a National Institutes of Health clinical trial has found.

10 Aug 2022

Epidural lidocaine injections show promise for treating psoriasis

Psoriasis is a chronic inflammatory, debilitating skin disorder. Although there is no cure for psoriasis, several treatment options can inhibit inflammation and relieve signs and symptoms of this disease.

10 Aug 2022

How effective is tecovirimat as a treatment against monkeypox?

A new study evaluated the use of tecovirimat for monkeypox treatment during the current outbreak.

9 Aug 2022

Combination therapy regimen for cystic fibrosis is also beneficial to primary school-aged children

Cystic fibrosis remains an incurable genetic disorder which impairs lung function and significantly reduces life expectancy.

8 Aug 2022

Trial evaluates sugemalimab as a consolidation treatment in patients with unresectable stage III NSCLC

The human monoclonal antibody sugemalimab is a safe and effective consolidation therapy for patients with unresectable stage III non-small cell lung cancer without disease progression after either concurrent chemoradiotherapy (cCRT) or sequential chemoradiotherapy (sCRT), according to findings presented today at the IASLC World Conference on Lung Cancer 2022 in Vienna.

8 Aug 2022

Inhaled aprotinin found to reduce viral load in mild-to-moderate COVID-19

A recent paper describes the use of aprotinin, a protease inhibitor that works across several pathways, to reduce the severity of COVID-19.

8 Aug 2022

The safety and preliminary efficacy of OP-101 in patients with severe COVID-19

Researchers assessed the impact of dendrimer nanotherapy in treating severe COVID-19.

8 Aug 2022

Varenicline and cytisine not more efficacious than nicotine to treat risky drinking and smoking, study says

A clinical trial to test whether three proven smoking cessation treatments could also reduce alcohol intake found no differences between the medications, but the rates of behavior change for alcohol consumption and smoking were high in all treatment groups. Results suggest these medications could play an important role to reduce alcohol use and smoking at the same time. Unexpectedly, nicotine replacement therapy performed as well as the prescription drugs varenicline and cytisine.

8 Aug 2022

Benefits of tocolytics outweigh any risks linked with unwanted side effects, study finds

Women around the world should be able to access the best medical treatments that help to delay preterm births and improve neonatal outcomes, new research suggests.

5 Aug 2022

Placebo News and Research

SGLT2 inhibitors reduce cardiovascular events among heart failure patients with mildly reduced and preserved ejection fraction

Adding acetazolamide to intravenous loop diuretics decreases congestion in patients with acute decompensated heart failure

Sociology professor finds three distinct themes in anti-COVID-19 vaccination protest slogans

New study investigates a potential treatment for people diagnosed with monkeypox

The safety, tolerability, and pharmacokinetics of a muco-trapping monoclonal antibody delivered by inhalation

Glucokinase activator AZD1656 shows potential benefit for diabetics with moderate to severe COVID-19

Direct acting antiviral medications for hepatitis C may improve PTSD symptoms

The effectiveness of three repurposed drugs in preventing serious SARS-CoV-2 infection in non-hospitalized adults

The BCG vaccine against COVID-19 and other infectious diseases in type 1 diabetic adults

Vitamin D promising for depression, study says

Azelastine nasal spray could decrease SARS-CoV-2 load

Monoclonal antibody decreases asthma attacks by 27% in children and adolescents of color

Epidural lidocaine injections show promise for treating psoriasis

How effective is tecovirimat as a treatment against monkeypox?

Combination therapy regimen for cystic fibrosis is also beneficial to primary school-aged children

Trial evaluates sugemalimab as a consolidation treatment in patients with unresectable stage III NSCLC

Inhaled aprotinin found to reduce viral load in mild-to-moderate COVID-19

The safety and preliminary efficacy of OP-101 in patients with severe COVID-19

Varenicline and cytisine not more efficacious than nicotine to treat risky drinking and smoking, study says

Benefits of tocolytics outweigh any risks linked with unwanted side effects, study finds

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News